-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 15, Haisco issued an announcement stating that its wholly-owned subsidiary, Liaoning Haisco, had recently received the "Drug Registration Certificate" for propofol medium/long-chain fat emulsion injection issued by the State Drug Administration
.
This product is a short-acting intravenous general anesthetic that can be used for:
Induction and maintenance of general anesthesia in adults and children over 1 month
.
Adults and children over one month of diagnostic procedures and sedation during surgery can be used alone or in combination with local anesthesia or regional anesthesia
Propofol medium/long-chain fat emulsion injection is a fast and short-acting intravenous anesthetic.
It has the advantages of fast onset, stable induction, short duration, quick and complete recovery, and can reduce the degree and incidence of injection pain , Respiratory depression is light, clinical adverse reactions are few, and the application is safe and quick.
It has become an indispensable intravenous general anesthetic in clinical practice
.
Propofol injection prepared with medium-chain triglycerides and long-chain triglycerides (soybean oil) at the same time can reduce the adverse reactions that are easily caused by large-dose or long-term continuous use of long-chain fat emulsions, such as hyperlipidemia, Damage the immune system and affect the function of important organs such as the reticuloendothelial system and liver
According to the nationally enlarged data of Minai.
